DescriptionCurator's Comment: description was created based on several sources, including:
https://www.drugs.com/npc/gamma-oryzanol.html
http://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm275973.pdf
Curator's Comment: description was created based on several sources, including:
https://www.drugs.com/npc/gamma-oryzanol.html
http://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm275973.pdf
Gamma-oryzanol is a naturally occurring component in rice bran and rice germ, which consists of a mixture of ferulic acid esters of sterols and triterpene alcohols. The mechanism of action of gamma-oryzanol is believed to be involved in the metabolism of catecholamine in the hypothalamus. The antioxidant effect of gamma-oryzanol was well documented and excellent in inhibiting lipid peroxidation. Isolation, extraction, and purification of gamma oryzanol were first reported in the mid-1950s. It has been sold in Japan as a medicine since 1962, first to treat anxiety and later in menopause. Gamma oryzanol and rice bran oil therapy have been used to manage elevated cholesterol and triglyceride levels since the late 1980s. No human clinical studies reported adverse effects of rice bran or its fiber fraction.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
25.0 µM [IC50] | |||
38.0 µM [IC50] | |||
Target ID: GO:0034440 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | ORURU Approved UseIt is usually used to improve various symptoms associated with climacteric disturbance Launch Date1980 |
|||
Primary | ORURU Approved UseIt is usually used to treat hyperlipidemia. Launch Date1980 |
|||
Palliative | ORURU Approved UseIt is usually used to improve various symptoms associated with irritable bowel syndrome Launch Date1980 |
PubMed
Title | Date | PubMed |
---|---|---|
Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model. | 1991 Oct |
|
Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. | 2006 Mar |
|
Upregulation of genes related to bone formation by γ-amino butyric acid and γ-oryzanol in germinated brown rice is via the activation of GABAB-receptors and reduction of serum IL-6 in rats. | 2013 |
|
γ-Oryzanol protects against acute cadmium-induced oxidative damage in mice testes. | 2013 May |
Patents
Sample Use Guides
The dosage against hyperlipemia is 300 mg per day for adult, and against menopausal symptoms and mild anxiety is 10 to 50 mg per day; 6 mg once a day for 3 months for anti-inflammatory effect on skin
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16005170
Gamma-oryzanol is able to inhibit lipid soluble organic radicals at oncentration of 50–100M.
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29701
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
||
|
DSLD |
1419 (Number of products:112)
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C013172
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | |||
|
γ-Oryzanol
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | |||
|
SST9XCL51M
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | |||
|
800
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | |||
|
m8253
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | Merck Index | ||
|
1479202
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | |||
|
SUB14720MIG
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | |||
|
SST9XCL51M
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | |||
|
25608
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | RxNorm | ||
|
C65799
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106452
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | |||
|
SUB91960
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | |||
|
DTXSID6021084
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY | |||
|
11042-64-1
Created by
admin on Sat Dec 16 08:45:54 GMT 2023 , Edited by admin on Sat Dec 16 08:45:54 GMT 2023
|
PRIMARY |
All of the following components must be present:
ACTIVE MOIETY